Horizon Genomics

Horizon Genomics Overview

Status Acquired/​Merged
Employees 11
Employees
Latest Deal Type M&A
Financing Rounds 1

Horizon Genomics General Information

Description

Provider of biotechnological services. The company specializes in managing human cell products such as haploid human cell lines used to generate model cell lines for functional genomics studies.

Contact Information

Formerly Known As
Haplogen Genomics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Campus Vienna Biocenter 5
  • Vienna, 1030
  • Austria
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Horizon Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Horizon Genomics‘s full profile, request access.

Request a free trial

Horizon Genomics Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
ToolGen Corporation Seoul, South Korea 00
00000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Berkeley, CA 00 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed Cambridge, MA 000 0000 000000 - 000 0000
00000000 Venture Capital-Backed Redwood City, CA 000 00000 00000000000 00000

Horizon Genomics Executive Team (2)

Name Title Board Seat Contact Info
Darrin Disley Ph.D Co-Chief Executive Officer
Thomas Moser Ph.D General Manager